ENG rs730880096: Understanding Hereditary Hemorrhagic Telangiectasia
The rs730880096 variant is a specific genetic change located within the ENG gene. This gene is primarily associated with hereditary hemorrhagic telangiectasia (HHT), a condition characterized by abnormal blood vessel development.
What each genotype means
Typical endoglin function
This genotype represents the most common, non-variant form of this site in the ENG gene. It is associated with typical endoglin protein production and does not suggest an increased genetic risk for hereditary hemorrhagic telangiectasia linked to this specific variant.
This is the most common genotype observed in global populations.
Potential HHT1 association
This genotype indicates that you carry one copy of the variant. Research suggests that individuals with pathogenic variants in ENG may experience endoglin haploinsufficiency, which is associated with hereditary hemorrhagic telangiectasia type 1. Please discuss this finding with a healthcare provider or genetic counselor who can interpret this result within the context of your personal and family medical history.
This genotype is extremely rare in the general population.
Potential HHT1 association
This genotype indicates that you carry two copies of the variant. In the context of ENG-related conditions, carrying variants in this gene is often linked to vascular changes seen in hereditary hemorrhagic telangiectasia. Clinical evaluation by a specialist is recommended to understand the implications for your vascular health, as research on specific homozygous states for this rare variant is limited.
This genotype is exceptionally rare, with no significant representation in standard population frequency databases.
What is the rs730880096 Variant?
The rs730880096 variant is a single nucleotide polymorphism (SNP) found within the ENG gene, which is located on chromosome 9. In genomics, a SNP represents a variation at a single position in the DNA sequence. While many SNPs are common and have no impact on health, others can alter the function of the protein encoded by the gene. The ENG gene provides the blueprint for a protein called endoglin. When a variant occurs in this gene, it may affect how endoglin is produced or how it functions within the body. Researchers track these specific variants to understand their potential role in inherited conditions. Because rs730880096 is cataloged in databases like dbSNP, scientists can study its presence across different populations to determine if it contributes to specific clinical traits or disease risks.
The Role of the ENG Gene
The ENG gene is essential for the production of endoglin, a protein found on the surface of endothelial cells, which line the interior of blood vessels. Endoglin acts as a critical component of the transforming growth factor-beta (TGF-beta) receptor complex. This signaling pathway is vital for the proper development and maintenance of the vascular system, particularly in the formation of boundaries between arteries and veins. When the ENG gene is mutated, the resulting endoglin protein may be absent, reduced, or dysfunctional. This disruption interferes with normal angiogenesis—the process of forming new blood vessels—and can lead to the development of arteriovenous malformations. These are abnormal connections between arteries and veins that bypass the capillary system, which is a hallmark of hereditary hemorrhagic telangiectasia (HHT).
Research and Clinical Associations
The ENG gene is well-established in medical literature as a primary cause of hereditary hemorrhagic telangiectasia type 1 (HHT1). HHT is an autosomal dominant disorder, meaning that a single copy of a pathogenic variant is sufficient to cause the condition. Clinical diagnosis of HHT is typically based on the Curaçao criteria, which include symptoms like recurrent nosebleeds, mucocutaneous telangiectasias, and visceral arteriovenous malformations. While many variants in ENG are known to be pathogenic, the clinical significance of any specific variant, such as rs730880096, must be evaluated by clinical geneticists using standardized criteria. Evidence for specific variants is often gathered through family studies and clinical sequencing. It is important to note that the presence of a variant does not automatically guarantee the development of severe symptoms, as penetrance and expressivity can vary significantly between individuals.
Population Frequency and Interpretation
The rs730880096 variant is classified as rare in the general population. In genomics, rare variants are those that appear at a very low frequency across diverse ancestral groups. Because this variant is rare, it is not typically found in the general screening panels used for common trait analysis. When a variant is rare, it is often more challenging to establish a definitive clinical impact without additional data from family history or functional studies. Researchers use large-scale databases like gnomAD to estimate how often these variants occur in healthy populations versus those with specific clinical diagnoses. If you have received information about this variant from a genetic test, it is essential to discuss the findings with a genetic counselor or a healthcare provider who can interpret the results in the context of your personal and family medical history.
Managing Genetic Information
Genetic information regarding variants in the ENG gene should be handled with care. If you are concerned about HHT or have a family history of vascular anomalies, the most appropriate step is to consult with a medical professional. A clinical geneticist can determine if genetic testing is warranted and help interpret what a specific result means for your health. You cannot diagnose yourself based on a single SNP result, as clinical diagnosis relies on a combination of genetic testing, physical examination, and medical history. Avoid making medical decisions based solely on online reports. Instead, use this information as a starting point for a conversation with your doctor. They can provide guidance on whether further screening, such as imaging for arteriovenous malformations, is necessary for you or your family members.
How common is this variant?
The rs730880096 variant is considered rare, with a very low frequency observed across global populations in genomic databases.
Frequently asked questions
What is hereditary hemorrhagic telangiectasia?
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder that causes abnormal blood vessel formation, often leading to nosebleeds and vascular malformations in organs like the lungs, liver, or brain.
Does having an ENG variant mean I have HHT?
Not necessarily. While pathogenic variants in ENG are a known cause of HHT, a clinical diagnosis is usually based on specific physical symptoms and family history, not just a genetic test result.
How is HHT diagnosed?
HHT is typically diagnosed using the Curaçao criteria, which look for symptoms like spontaneous nosebleeds, telangiectasias, and visceral arteriovenous malformations, often supported by genetic testing.
Should I be worried about this variant?
If you have concerns about a genetic variant, you should consult a genetic counselor or your primary care physician. They can help you understand the results in the context of your health.
Where can I find more information on ENG?
You can find reliable information on the ENG gene through resources like MedlinePlus Genetics, the NCBI Gene database, and GeneReviews.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs730880096?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ENG
Genetic variant identified in the ENG gene, relevant for clinical screening of vascular disorders.
A known pathogenic mutation in the ENG gene linked to vascular malformations.
Pathogenic variant in the ENG gene associated with hereditary hemorrhagic telangiectasia type 1.
A variant in the ENG gene potentially impacting protein function related to vascular development.
This variant is located within the ENG gene, which is associated with hereditary hemorrhagic telangiectasia.
Clinically significant variant in the ENG gene associated with hereditary hemorrhagic telangiectasia.
